1. Home
  2. Analysis
  3. Fosrenol
  4. Auryxia

Fosrenol and Auryxia drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fosrenol (lanthanum carbonate) and Auryxia (ferric citrate). Common drug interactions include chronic kidney disease among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Fosrenol and Auryxia. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Fosrenol?

Fosrenol has active ingredients of lanthanum carbonate. eHealthMe is studying from 5,922 Fosrenol users. Check the latest studies of Fosrenol.

What is Auryxia?

Auryxia has active ingredients of ferric citrate. eHealthMe is studying from 2,253 Auryxia users. Check the latest studies of Auryxia.

On Jul, 08, 2026

20 people who take Fosrenol and Auryxia together, and have interactions are studied.

Fosrenol and Auryxia drug interactions.

What are the common drug interactions of Fosrenol and Auryxia, by gender? *:

female:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Renal failure (kidney dysfunction)
  4. Renal impairment (severely reduced kidney function)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Depression
  8. Device dislocation
  9. Diarrhoea
  10. Emotional distress

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Depression
  4. Diarrhoea
  5. Quality of life decreased
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  7. Asthenia (weakness)
  8. Blood parathyroid hormone increased
  9. Cough
  10. Dialysis related complication

What are the common drug interactions of Fosrenol and Auryxia, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Chronic kidney disease
  6. Renal failure (kidney dysfunction)
  7. Depression

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Fatigue (feeling of tiredness)
  5. Pain
  6. Decreased activity
  7. Quality of life decreased
  8. Chronic kidney disease
  9. Depression
  10. Device dislocation

50-59:

  1. Chronic kidney disease
  2. Cough
  3. Iron overload
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Renal failure (kidney dysfunction)
  6. Renal impairment (severely reduced kidney function)
  7. Transferrin saturation increased

60+:

  1. Diarrhoea
  2. Postoperative wound infection
  3. Dialysis related complication
  4. Discomfort
  5. Dizziness
  6. Drug ineffective
  7. Faeces discoloured
  8. Fatigue (feeling of tiredness)
  9. Hypervolaemia (abnormally increased volume of blood)
  10. Iron deficiency

What are the existing conditions these people have? *

  1. Hyperkalemia (damage to or disease of the kidney): 7 people, 35.00%
  2. Hiv Infection: 7 people, 35.00%
  3. Diabetes: 3 people, 15.00%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 15.00%
  5. Gastrointestinal Motility Disorder (abnormal intestinal contractions): 3 people, 15.00%
  6. Sleep Disorder: 3 people, 15.00%
  7. Affective Disorder (mental disorder): 3 people, 15.00%
  8. Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 2 people, 10.00%
  9. Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 10.00%
  10. Rickets (softening of bones): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Fosrenol and Auryxia?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fosrenol and Auryxia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fosrenol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Auryxia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fosrenol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Auryxia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on lanthanum carbonate and ferric citrate (the active ingredients of Fosrenol and Auryxia, respectively), and Fosrenol and Auryxia (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.